Efficacy and Safety of Low-Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial
Prajapati H, Satia M, Shah D, Basera I
Published in Phytotherapy Research
Methodology
Eight-week randomised, double-blind, placebo-controlled trial of low-dose ashwagandha root extract (30 mg/day, standardised to >15% withanolides) versus placebo in healthy adults, assessing cardiorespiratory fitness and exercise-induced fatigue
Key Findings
Low-dose ashwagandha supplementation was evaluated for cardiorespiratory fitness and exercise-induced fatigue in healthy adults over eight weeks, with a favourable safety profile reported.
Conclusions
A bioactive-optimised low-dose ashwagandha extract is a candidate for supporting exercise endurance, pending independent replication.
Limitations
Single trial of a proprietary branded extract, industry-linked, results need independent confirmation.
Supplements Studied
This study investigated the efficacy and safety of LDA supplementation on cardiorespiratory fitness and exercise-induced fatigue in healthy individuals.
Outcomes Measured
This study investigated the efficacy and safety of LDA supplementation on cardiorespiratory fitness and exercise-induced fatigue in healthy individuals.
Study Details
Access Study
Disclosures
Funding
Manufacturer-linked clinical trial
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.